Inhibitors of protein kinase C

Chinese Science Bulletin

Volumn 50, Issue 13, 2005, Pages 1293-1304

  Liu, Shiying ^a,b   Jiang, Yuyang ^a   Cao, Jian ^b   Liu, Feng ^b   Ma, Li ^c   Zhao, Yufen ^a  

^a TSINGHUA UNIVERSITY   (China)

^b HENAN UNIVERSITY OF TECHNOLOGY   (China)

^c Beijing Biological Medicine Institute   (China)

Author keywords

Inhibitor; Protein kinase C; Signal transduction

Indexed keywords

EID: 33749663647     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1360/982004-328     Document Type: Review

References (34)

1. Xu, W. C., Zhou, Q., Ashendel, C. L. et al., Novel protein kinase C inhibitors: synthesis and PKC inhibition of β-substituted polythiophene derivatives, Bioorganic & Medicinal Chemistry Letters, 1999, 9: 2279-2282.
2. Scapin, G., Structural biology in drug design: selective protein kinase inhibitors, DDT, 2002, 7(11): 601-611.
3. Liu, J. P., Protein kinase C and its substrates, Molecular and Cellular Endocrinology, 1996, 116: 1-29.
4. Way, K. J., Chou, E., King, G. L., Identification of PKC-isoform-specific biological actions using pharmacological approaches, Tips, 2000, 21: 181-187.
5. Pei, G., Inhibitors of protein kinases and protein phospholipases, Life Science (in Chinese), 1995, 7(3): 33-39.
6. Yang, G. Z., Research of inhibitors in plants of protein kinase C, Chemistry of Life (in Chinese), 1998, 18 (3): 19-21.
7. Ji, S. P., Yao, L. B., Protein kinase C and cell cycle, Chinese Bulletin of Life Science (in Chinese), 2001, 13 (1): 37-40.
8. Fabbro, D., Ruetz, S., Buchdunger, E. et al., Protein kinases as targets for anticancer agents: from inhibitors to useful drugs, Pharmacology & Therapeutics, 2002, 93: 79-98.
9. Wang, Z., Canagarajah, B. J., Boehm, J. C. et al., Structural basis of inhibitor selectivity in MAP kinases, Structure, 1998, 6: 1117-1128.
10. Schinaler, T., Sicheri, F., Pico, A. et al., Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor, Mol. Cell., 1999, 3: 639-648.
11. Hu, H., Recent discovery and development of selective protein kinase C inhibitors, DDT, 1996, 1: 438-447.
12. Lee, J. C., Adams, J. L., Inhibition of serine/threonine kinases, Current Opinion in Biotechnology, 1995, 6: 657-661.
13. Yoshikawa, N., Nakamura, K., Yamaguchi, Y. et al., Effect of PKC412, a selective inhibitor of protein kinase C, on lung metastasis in mice injected with B16 melanoma cells, Life Science, 2003, 72: 1377-1387.
14. Martiny-Baron, G., Kazanietz, M. G., Mischak, H. et al., Selective inhibition of protein kinase C by the indolocarbazole GÖ6976, The Journal of Biological Chemistry, 1993, 268 (13): 9194-9197.
15. s6k: implications for the analysis of S6K signaling, FEBS Letters, 2002, 519: 135-140.
16. Teicher, B. A., Alvarez, E., Mendelsohn, L. G. et al., Enzymatic rational and preclinical support for a potent protein kinase Cβ inhibitor in cancer therapy, Advan. Enzyme Regul., 1999, 39: 313-327.
17. Clerk, A., Death by protein kinase C inhibitor: a Stressful Event, J. Mol. Cell Cardiol., 2001, 33: 1773-1776.
18. Cai, Y., Ou, Y. L., Research on structure-activity relation of gleevec, Chinese Journal of Medicinal Chemistry (in Chinese), 2002, 12(5): 276-278.
19. Liu, G. S., Cohen, M. V., Mochly-Rosen, D. et al., Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes, J. Mol. Cell Cardiol., 1999, 31: 1937-1948.
20. Ono-Saito, N., Niki, I., Hidaka, H., H-series protein kinase inhibitors and potential clinical applications, Pharmacol. Ther., 1999, 82(2-3): 123-131.
21. Parang, K., Cole, P. A., Designing bisubstrate analog inhibitors for protein kinases, Pharmacology & Therapeutics, 2002, 93: 145-157.
22. Loog, M., Uri, A., Raidaru, G., Adenosine-5′-carboxylic acid peptidyl derivatives as inhibitors of protein kinase, Bioorgnic & Medicinal Chemistry Letters, 1999, 9: 1447-1452.
23. Yedovitzky, M., Mochly-Rosen, D., Johnson, J. A., Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic β-Cells, The Journal of Biological Chemistry, 1997, 272(3): 1417-1420.
24. Johnson, J. A., Gray, M. O., Chen, C. H. et al., A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function, The Journal of Biological Chemistry, 1996, 271(40): 24962-24966.
25. Ron, D., Luo, J. H., Mochly-Rosen, D., C2 region-derived peptides inhibit translocation and function of β protein kinase C in vivo, The Journal of Biological Chemistry, 1995, 270(41): 24180-24187.
26. Harris, T. E., Persaud, S. J., Jones, P. M., Pseudosubstrate peptide inhibitors of β-cell protein kinases: altered selectivity after myristoylation, Molecular and Cellular Endocrinology, 1999, 155: 61-68.
27. Slater, S. J., Seiz, J. L., Cook, A. C. et al., Inhibition of protein kinase C by resveratrol, Biochimica et Biophysica Acta, 2003, 1637: 59-69.
28. Cohen, P., The development and therapeutics potential of protein kinase inhibitors, Current Opinion in Chemical Biology, 1999, 3: 459-465.
29. Dean, N. M., McKay, R., Condon, T. P. et al., Inhibition of protein kinase C-a expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters, The Journal of Biological Chemistry, 1994, 269(23): 16416-16424.
30. Liu, J. D., Zhang, Q. L., Advance in research of apoptosis in promoting new drugs development, Chinese New Drugs Journal (in Chinese), 1999, 3 (5): 298-302.
31. McKay, R. J., Miraglia, L. J., Cummins, L. L. et al., Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-a expression, The Journal of Biological Chemistry, 1999, 274(3): 1715-1722.
32. Bonham, M. A., Brown, S., Boyd, A. L., An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers, Nucleic Acids Research, 1995, 23(7): 1197-1203.
33. Parker, P. J., Inhibition of protein kinase C-Do We, Can We, and Should We? Pharmacol. Ther., 1999, 82(2-3): 263-267.
34. Buolamwini, J. K., Novel anticancer drug discovery. Current Opinion in Chemical Biology, 1993, 3: 500-509.